Reporter Dec 13 2019 Archive — Page 1 of 2

Stylized microscopic illustration of translucent cells, including two connected cells with visible central nuclei, floating against a blue background.
December 17, 2019

Cell fate signaling

A newly identified protein interaction that affects cell cycle regulation may be an attractive target for cancer therapy.

By Leigh MacMillan
December 16, 2019

Protein dynamics in the beating heart

To study the dynamics of structural proteins in the heart, Vanderbilt investigators generated a cellular tool they expect will be useful for screening drugs that affect heart muscle contraction.

By Leigh MacMillan
Aerial view of Vanderbilt University’s historic campus, with Gothic Revival buildings, a construction crane, autumn trees, and a city skyline in the background.
December 12, 2019

Vanderbilt reports record $11.9 billion economic impact in Tennessee

Through a record $11.9 billion in annual economic impact, Vanderbilt University’s deep and broad connections to Tennessee and its people continue to be key and growing drivers of the state’s economy and to the vitality and well-being of its citizens and communities.

By Vanderbilt Health News
December 12, 2019

New training materials help clinicians stay opioid compliant

Vanderbilt University Medical Center, through the offices of its Opioid Oversight Executive Committee, is offering its employees an online tutorial, Opioid Laws — Prescribing at VUMC

By Paul Govern
A hawk perches on a tree branch amid leafy branches, with its patterned brown-and-white feathers lit by sunlight.
December 12, 2019

VUMC-led team isolates antibody that blocks bird flu

VUMC scientists are redoubling their efforts to help people fight off bird flu. Their focus is H7N9, one of the most dangerous of the influenza viruses that have been transmitted from birds to humans.

By Bill Snyder
Stylized green brain illustration with a bright yellow-green glow in the central left region against a black background.
December 12, 2019

A new anti-seizure target?

Vanderbilt neurologists have identified a protein modification that could be targeted to reduce neuronal excitability in epilepsy.

By Leigh MacMillan